Navigation Links
City of Hope Testing New Communication Link Between Cancer Therapy System and Elekta Electronic Medical Record System
Date:2/17/2010

ATLANTA, Feb. 17 /PRNewswire/ – City of Hope (Duarte, Calif.), a leading research and treatment center for cancer and other diseases, is the first medical center to implement an electronic interface that links its TomoTherapy® Hi-Art® treatment systems with the MOSAIQ® radiation oncology information management system. The connection enables communication between the MOSAIQ and the Hi-Art systems, facilitating access to vital information, such as the patient's treatment verification and documentation, insurance company data, and data and records between clinicians, scientists and outside laboratories involved in the patient's care.

"Essentially, the MOSAIQ-Hi-Art interface aims to improve patient safety and overall workflow. It aids in plan selection on the Hi-Art system and streamlines our department's efficiency by recording delivered treatments and charges," says Jeffrey Wong, M.D., Chairman, Department of Radiation Oncology. "The interface now allows us to schedule patient treatments for the Hi-Art in MOSAIQ and also to transfer and record treatment delivery information from the Hi-Art in the MOSAIQ patient chart. It further facilitates our tracking of the patient's accumulated dose and the capture of charges based on details exported from the treatment machine."

City of Hope used the predecessor to the MOSAIQ system—Multi-Access™—since September 1999, upgrading to MOSAIQ in September 2009. The open systems architecture of MOSAIQ enabled City of Hope to take advantage of a purpose-built interface to its two Hi-Art systems, acquired in 2004 and 2006.

"We felt we needed to further improve workflow and enhance treatment safety throughout the department," Dr. Wong notes. "Moreover, MOSAIQ provides several other advantages to our clinic environment. It's a very mature, time-tested product and affords a flexible platform to interface with technologies from a variety of vendors, which is a unique benefit in the oncology information systems market."

"The ability to partner with City of Hope in the MOSAIQ-Hi-Art interface is another example of Elekta Software's dedication to open systems and vendor-neutral connectivity," says Todd Powell, Senior Vice President, Elekta Software. "The benefit of this philosophy is the assurance of cross-platform flexibility to integrate the most advanced and useful tools to improve patient care."

City of Hope's radiation oncology department treats 110 patients daily. The center is one of only 40 National Cancer Institute-designated Comprehensive Cancer Centers nationwide. It is ranked as one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report.

About MOSAIQ®

The MOSAIQ radiation oncology electronic medical record (EMR) was designed to manage all the information found in a paper chart. With sophisticated diagnosis and staging features, order management, patient assessments, physician noting, transcriptions and medical oncology charting, MOSAIQ radiation oncology provides a comprehensive charting solution. With integrated practice management functionality, the system provides a total management solution that can support all members of the cancer care team.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

SOURCE Elekta

RELATED LINKS
http://www.elekta.com

'/>"/>

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition
2. China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits
3. Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes
4. ADIN Healthcare Identifies the Top Six Ways Employers Lose Money on Diagnostic Testing for Workplace Injuries
5. Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
6. AQUA(R) Technology Recognized as Promising New Strategy for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
7. TessArae Delivers Lower Cost Option to Genetic Testing Market
8. ASM Recommends Nasopharyngeal Flocked Swabs as the Specimen of Choice for Influenza A Testing (Including H1N1)
9. Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study
10. Ortho Clinical Diagnostics Receives FDA Approval for First Anti-HIV 1+2 Test for Use on Random Access, Integrated Laboratory Testing System
11. Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):